Connect your AI

10x Genomics, Inc. TXG Gross Profit

Gross Profit at other companies

TEC

Bio-TechneTECH

$208.29M-2.9%

BrukerBRKR

$379.8M-2.9%

IlluminaILMN

$721M+5.6%

Twist Bioscience CorporationTWST

$57.12M+24.1%

Bio-Rad LaboratoriesBIO

$309.4M+1.1%

RevvityRVTY

——

Other financials

Income statement

Revenue$150.8M-2.6%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

$150.8Mtotal revenue−$44.7Mtotal cost of revenue=$106.18M

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is 10x Genomics, Inc.'s gross profit?: 10x Genomics, Inc. (TXG) reported gross profit of $106.18M in Q1 2026.
How has 10x Genomics, Inc.'s gross profit changed year-over-year?: 10x Genomics, Inc.'s gross profit increased by 0.7% year-over-year, from $105.45M to $106.18M.
What is the long-term trend for 10x Genomics, Inc.'s gross profit?: Over 4 years (2021 to 2025), 10x Genomics, Inc.'s gross profit has grown at a 1.6% compound annual growth rate (CAGR), from $416.4M to $443.88M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.